XOMA XOMA PE ratio, current and historical analysis
The current PE ratio of XOMA cannot be calculated, as the latest EPS of -$2.45 is negative. XOMA's last PE ratio on record was 20.12 in September 2022.
XOMA PE ratio history
The mean historical PE ratio of XOMA over the last nine years is 43.73. Looking back at the last nine years, XOMA's PE ratio peaked in the Sep 2021 quarter at 130.26, with a price of $24.75 and an EPS of $0.19. The Mar 2018 quarter marked the lowest point at 13.67, with a price of $20.23 and an EPS of $1.48.
XOMA PE ratio by year
Maximum annual decrease: -43.85% in 2021
| Year | PE ratio | Change |
|---|---|---|
| 2023 | N/A | N/A |
| 2022 | N/A | N/A |
| 2021 | 30.22 | -43.85% |
| 2020 | 53.82 | N/A |
| 2019 | N/A | N/A |
| 2018 | N/A | N/A |
| 2017 | 47.47 | N/A |
| 2016 | N/A | N/A |
| 2015 | N/A | N/A |
| 2014 | N/A | N/A |
XOMA average PE ratio chart
XOMA PE vs peers
| Stock name | PE ratio | Market cap |
|---|---|---|
| NVS Novartis AG | 14.75 | $237.73B |
| REGN Regeneron Pharmaceuticals Inc | 24.76 | $110.04B |
| ABBV AbbVie Inc | 62.86 | $333.08B |
| LLY ELI LILLY & Co | 112.53 | $871.65B |
| EBS Emergent BioSolutions Inc | N/A | $483.57M |
| PFE Pfizer Inc | N/A | $165.86B |
| TEVA Teva Pharmaceutical Industries Ltd | N/A | $20.35B |
| XOMA XOMA Corp | N/A | $337.56M |
Frequently asked questions
What is XOMA's PE ratio?
The current price to earnings ratio of XOMA cannot be determined, as its EPS of -$2.45 is negative.
What is the 5-year average PE ratio for XOMA (XOMA)?
The average PE ratio for XOMA stock over the past 5 years is 51.66.
What is the highest PE ratio for XOMA?
Over the last nine years, the quarterly PE ratio reached its highest level at 130.26 in the Sep 2021 quarter.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.